GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » GlucoTrack Inc (NAS:GCTK) » Definitions » Cyclically Adjusted Price-to-FCF

GCTK (GlucoTrack) Cyclically Adjusted Price-to-FCF : (As of Jul. 01, 2025)


View and export this data going back to 2000. Start your Free Trial

What is GlucoTrack Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


GlucoTrack Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for GlucoTrack's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlucoTrack Cyclically Adjusted Price-to-FCF Chart

GlucoTrack Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GlucoTrack Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of GlucoTrack's Cyclically Adjusted Price-to-FCF

For the Medical Instruments & Supplies subindustry, GlucoTrack's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlucoTrack's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, GlucoTrack's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where GlucoTrack's Cyclically Adjusted Price-to-FCF falls into.


;
;

GlucoTrack Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

GlucoTrack's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, GlucoTrack's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-17.444/134.9266*134.9266
=-17.444

Current CPI (Mar. 2025) = 134.9266.

GlucoTrack Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -312.000 100.684 -418.112
201509 -336.750 100.392 -452.593
201512 -376.750 99.792 -509.393
201603 -127.500 100.470 -171.226
201606 -605.750 101.688 -803.750
201609 -372.000 101.861 -492.757
201612 -241.750 101.863 -320.220
201703 -286.750 102.862 -376.136
201706 -615.750 103.349 -803.888
201709 -379.000 104.136 -491.063
201712 -197.000 104.011 -255.555
201803 -357.000 105.290 -457.489
201806 -254.000 106.317 -322.351
201809 -340.500 106.507 -431.358
201812 -546.000 105.998 -695.013
201903 -413.500 107.251 -520.204
201906 -612.000 108.070 -764.092
201909 -537.000 108.329 -668.845
201912 -398.000 108.420 -495.303
202003 -502.000 108.902 -621.967
202006 -301.000 108.767 -373.393
202009 -265.333 109.815 -326.007
202012 -283.667 109.897 -348.274
202103 -311.000 111.754 -375.486
202106 -323.000 114.631 -380.186
202109 -298.000 115.734 -347.418
202112 -324.333 117.630 -372.025
202203 -421.667 121.301 -469.032
202206 -305.333 125.017 -329.536
202209 -202.667 125.227 -218.366
202212 -313.333 125.222 -337.617
202303 -437.667 127.348 -463.714
202306 -238.500 128.729 -249.983
202309 -470.000 129.860 -488.339
202312 -602.750 129.419 -628.399
202403 -750.250 131.776 -768.186
202406 -383.800 132.554 -390.670
202409 -835.000 133.029 -846.912
202412 -269.154 133.157 -272.731
202503 -17.444 134.927 -17.444

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GlucoTrack  (NAS:GCTK) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


GlucoTrack Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of GlucoTrack's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


GlucoTrack Business Description

Traded in Other Exchanges
N/A
Address
301 Route 17 North, Suite 800, Rutherford, New Jersey, NJ, USA, 07070
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on proven healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
Executives
Drew Sycoff director C/O ANDREW GARRETT INC, 52 VANDERBILT AVENUE - 20TH FLOOR, NEW YORK NY 10017
James S Cardwell officer: Chief Financial Officer CLINTON SQUARE, 75 S. CLINTON AVE., SUITE 510, ROCHESTER NY 14604
Erin Catherine Carter director 301 RTE 17 NORTH, STE. 800, RUTHERFORD NJ 07070
Allen Danzig director 301 RT 17 NORTH, SUITE 800, RUTHERFORD NJ 07070
Shimon D Rapps director C/O ANDREW GARRETT, INC., 52 VANDERBILT AVENUE SUITE 510, NEW YORK NY 10017
David Podwalski officer: Chief Commercial Officer 19 HA'YAHALOMIM ST., P.O. BOX 12163, ASHDOD L3 7760049
Michael Hauck director 19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049
John A Graham director, officer: Chief Executive Officer 19 HA'YAHALOMIM STREET, P.O. BOX 12163, ASHDOD L3 7760049
Sami Sassoun officer: Chief Financial Officer 39-06 ACKERMAN DRIVE, FAIR LAWN L3 7760049
Philip Darivoff director 1 FARMSTEAD ROAD, SHORT HILLS NJ 07078
Revan Schwartz director 19 HA'YAHALOMIM ST., P.O. BOX 12163, C/O INTEGRITY APPLICATIONS, INC., ASHDOD L3 7760049
Leslie Seff director PO BOX 59, 40 HELLBROOK LANE, ULSTER PARK NY 12487
Angela Strand Boydston director C/O AEROGEN, INC., 2071 STIERLIN COURT, MOUNTAIN VIEW CA 94043
Eran Hertz officer: Chief Financial Officer C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L3 78100
Israel B. Ehrlich director C/O INTEGRITY APPLICATIONS, INC., 102 HA'AVODA STREET, P.O. BOX 432, ASHKELON L3 L378100